- Not Fee assured
- Awaiting verification
Specialises in
- Urology
About me
Dr Nicholas Van As qualified in medicine in 1995 in South Africa and completed specialist training in clinical oncology at Guy’s and St Thomas’ Hospital, The Royal Marsden and The Institute of Cancer Research.
Dr Van As specialises in urological cancers. He has research interests in stereotactic and image-guided radiotherapy, risk prediction in early prostate cancer, and functional MRI. He has published numerous papers and delivered presentations at international meetings.
Dr Van As is the clinical lead for CyberKnife and leads the stereotactic radiotherapy MDT at The Royal Marsden. He is the chief investigator on the PACE trial. This is the largest international trial looking at stereotactic radiotherapy for prostate cancer. CyberKnife is an exciting new technology which allows the accurate delivery of high-dose image-guided radiotherapy. It has been operational at The Royal Marsden since summer 2011.
Areas of interest
Urological oncology; Radiotherapy; SBRT; SABR; Cyberknife; Systemic therapy for prostate cacner
Medical secretaries
- Ganga Gurung
- Royal Marsden Hospital Fulham Road LONDON SW3 6JJ
- 020 7811 8336
- 020 7811 8338
- nick.vanaspa@rmh.nhs.uk
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0004
Clinical supervision and planning for delivery of chemotherapy cycle 1 - 28 days - (5-50)
-
X6581
Clinical supervision of the delivery of a single fraction of radiotherapy - (5-50)
The Royal Marsden Hospital (5-50)
-
X0003
Clinical supervision and planning for delivery of chemotherapy cycle 1 - 21 days - (5-50)
The Royal Marsden Hospital (5-50)
-
X6772
Preparation for complex radiotherapy with Intensity Modulated Radiotherapy (IMRT) - (5-50)
The Royal Marsden Hospital (5-50)
-
X0008
Clinical supervision of external beam radiotherapy, for 16 or up to and including 30 fractions - (5-50)
The Royal Marsden Hospital (5-50)
- Show All (6)...